Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
415.22
276.88
301.70
300.34
308.97
326.39
305.69
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
415.22
276.88
301.70
300.34
308.97
326.39
305.69
Raw Material Cost
246.48
150.68
140.35
148.84
148.96
151.03
134.64
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.54
7.35
8.97
8.32
7.27
7.91
7.49
Selling and Distribution Expenses
42.41
36.25
45.13
48.77
64.45
54.00
70.86
Other Expenses
1.20
1.31
0.61
0.29
0.59
0.51
1.31
Total Expenditure (Excl Depreciation)
308.41
207.38
200.60
208.82
226.60
218.04
226.07
Operating Profit (PBDIT) excl Other Income
106.8
69.5
101.1
91.5
82.4
108.3
79.6
Other Income
1.63
-2.07
4.14
1.93
7.15
14.85
24.97
Operating Profit (PBDIT)
146.17
109.97
136.54
136.14
123.50
162.22
132.89
Interest
7.54
7.35
8.97
8.32
7.27
7.91
7.49
Exceptional Items
0.00
0.46
1.14
0.68
0.96
1.00
0.25
Gross Profit (PBDT)
168.75
126.20
161.34
151.50
160.01
175.36
171.05
Depreciation
46.16
46.16
45.04
45.04
43.56
43.56
40.21
Profit Before Tax
92.47
56.91
83.67
83.45
73.63
111.75
85.44
Tax
10.82
6.64
12.87
10.94
8.59
15.24
17.69
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
81.65
50.27
70.81
72.51
65.04
96.51
67.74
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
81.65
50.27
70.81
72.51
65.04
96.51
67.74
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
81.65
50.27
70.80
72.51
65.03
96.51
67.74
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,575.56
3,541.91
3,230.69
3,418.29
3,345.75
3,342.67
2,959.98
Earnings per share (EPS)
0.14
0.09
0.11
0.12
0.1
0.18
0.12
Diluted Earnings per share
0.14
0.09
0.11
0.12
0.1
0.18
0.12
Operating Profit Margin (Excl OI)
23.69%
23.79%
28.96%
29.69%
23.56%
31.8%
22.15%
Gross Profit Margin
33.39%
37.23%
42.66%
42.78%
37.93%
47.59%
41.1%
PAT Margin
19.66%
18.16%
23.47%
24.14%
21.05%
29.57%
22.16%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 34.37% vs 18.12% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 25.69% vs 28.46% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 24.14% vs 24.76% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 2.74% vs -19.78% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Zhejiang Garden Biopharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
415.22
0
415.22
Other Operating Income
0.00
0.00
0.00
Total Operating income
415.22
0
415.22
Raw Material Cost
246.48
0
246.48
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
7.54
0
7.54
Selling and Distribution Expenses
42.41
0
42.41
Other Expenses
1.20
0.00
1.20
Total Expenditure (Excl Depreciation)
308.41
0
308.41
Operating Profit (PBDIT) excl Other Income
106.81
0.00
106.81
Other Income
1.63
0
1.63
Operating Profit (PBDIT)
146.17
0
146.17
Interest
7.54
0
7.54
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
168.75
0
168.75
Depreciation
46.16
0
46.16
Profit Before Tax
92.47
0
92.47
Tax
10.82
0
10.82
Provisions and contingencies
0
0
0.00
Profit After Tax
81.65
0
81.65
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
81.65
0
81.65
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.00
0
-0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
81.65
0
81.65
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,575.56
0
3,575.56
Earnings per share (EPS)
0.14
0
0.14
Diluted Earnings per share
0.14
0
0.14
Operating Profit Margin (Excl OI)
23.69%
0%
0.00
23.69%
Gross Profit Margin
33.39%
0%
0.00
33.39%
PAT Margin
19.66%
0%
0.00
19.66%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 41.52 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 49.95% vs -8.22% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 34.37% vs 18.12% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 8.17 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 62.43% vs -28.95% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 25.69% vs 28.46% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.45 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 29.02% vs -15.41% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 24.14% vs 24.76% in Jun 2025
Quarterly - Interest
Interest 0.75 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 1.35% vs -17.78% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 2.74% vs -19.78% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.69%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
